Tweeter button Delicious button Digg button Stumbleupon button
Liver Diseases | Ocera Therapeutics To Present At BIO Investor On October 8, 2013

SAN DIEGO, Sept. 25, 2013 (GLOBE NEWSWIRE) — Ocera Therapeutics ( OCRX ), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, today announced that Linda Grais, M.D., president and chief executive officer, will present at the 12th Annual BIO Investor Forum taking place at the Palace Hotel in San Francisco, CA October 8-9, 2013. Ocera’s presentation is scheduled for Tuesday at 04:00 PM PT in the Sea Cliff Presentation Room.


A live audio webcast of the presentation will be available in the “Investors” section of Ocera’s website, www.ocerainc.com .

About Ocera Therapeutics

Ocera Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on the development and commercialization of proprietary compounds to treat


Click here to view rest of article from original site


Facebook Twitter Email

Important Disclaimer: Article Comments provided are for general information purposes only and are not intended to substitute for informed professional medical, psychological, tax, accounting, legal, investment, or any other professional advice. We expressly disclaim liability for any product, manufacturer, distributor, service or service provider mentioned or any opinion expressed in these comments or anywhere else within the site. Lastly, we do not endorse any article or comment. Use at your own risk.